Latest filing published 25 Jun 2021 for CEN Biotech INC.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Alex Tarrabain: trading record in brief
All filings by Alex Tarrabain on record concern CEN Biotech Inc, in the capacity of finance chief. We count 9 filings; the first trade dates from 16 January 2021 and the latest from 25 June 2021.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Most recently, on 25 June 2021, the filings show a transaction in CEN Biotech Inc. Typically, a trade is published a median of 58 days after it takes place. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Alex Tarrabain
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,000,000 shares0Common StockSEC:0001437749-21-015701:0
- 3,000 shares0Common StockSEC:0001437749-21-014023:0
2 of 2 declarations